Skip to main content
National Patient Survey 2024 logo.Our National Patient Survey 2024 report is now live. Thank you to all those that shared their experiences. Read our report here.

PGT-M conditions

The page below lists all PGT-M conditions currently authorised and awaiting consideration by the HFEA.

When publishing genetic conditions on the authorised list, we aim to be as consistent as possible with the OMIM database. However, many conditions may have several different names and we would recommend searching the list using the OMIM number for the condition as this is less likely to change throughout time.

If a condition does not appear on the list, it does not necessarily mean the condition has specifically not been authorised, it may mean that we have never before received an application from a UK centre to perform PGT-M for this condition and it has therefore never been considered by the HFEA.

Please note that we are always processing new applications to add genetic conditions to the list from UK centres licensed to perform PGT-M. This may mean that some authorised conditions may not be displayed. If you are unsure if a condition has been authorised or not, or would like any further information please contact the PGTM team at pgtm@hfea.gov.uk.

Click here for a downloadable list: approved condition list. Please note that the website page below is updated more regularly and is therefore more accurate than the downloadable list.

Condition name Status OMIM number Documents
Myasthenic Syndrome, Congenital, 4A, Slow-Channel (CMS4A) approved 605809
Myasthenic Syndrome, Congenital, 4B, Fast-Channel (CMS4B) approved 616324
Myasthenic Syndrome, Congenital, 4C, Associated with Acetylcholine Receptor Deficiency (CMS4C) approved 608931
Myasthenic Syndrome, Congenital, 5 (CMS5) approved 603034
Myasthenic Syndrome, Congenital, 6, Presynaptic (CMS6) approved 254210
Myasthenic Syndrome, Congenital, 7A, Presynaptic, and Distal Motor Neuropathy, Autosomal Dominant (CMS7A) approved 616040
Myasthenic Syndrome, Congenital, 8 (CMS8) approved 615120
Myasthenic Syndrome, Congenital, 9, Associated with Acetylcholine Receptor Deficiency (CMS9) approved 616325
Myelodysplastic Syndrome (MDS) approved 614286
Myoclonic Epilepsy and Ragged Red Fibres (MERRF) approved 545000
Myoclonic Epilepsy of Unverricht-Lundborg Disease (ULD-EPM1) approved 254800
Myofibromatosis, Infantile, 1 (IMF1) approved 228550
Myopathy, Centronuclear, 1 (CNM1) approved 160150
Myopathy, Myofibrillar, 1 (MFM1) approved 601419
Myopathy, Myofibrillar, 10 (MFM10) approved 619040
Myopathy, Myofibrillar, 2 (MFM2) approved 608810
Myopathy, Myofibrillar, 3 (MFM3) approved 609200
Myopathy, Myofibrillar, 4 (MFM4) approved 609452
Myopathy, Myofibrillar, 5 (MFM5) approved 609524
Myopathy, Myofibrillar, 6 (MFM6) approved 612954